The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Induced Pluripotent Stem Cells Production Market Research Report 2025
Synopsis
Induced Pluripotent Stem Cells (iPSC) are generated from skin or blood cells that have been reprogrammed into an embryonic-like pluripotent state, allowing to produce an infinite source of any kind of human cell required for therapeutic reasons.
The global Induced Pluripotent Stem Cells Production market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Induced Pluripotent Stem Cells Production is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Induced Pluripotent Stem Cells Production is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Induced Pluripotent Stem Cells Production include Lonza, Axol Bioscience Ltd., Evotec, Hitachi Ltd., Merck KGaA, REPROCELL Inc., Fate Therapeutics, Thermo Fisher Scientific, Inc. and StemCellFactory III, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Induced Pluripotent Stem Cells Production, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Induced Pluripotent Stem Cells Production.
Report Scope
The Induced Pluripotent Stem Cells Production market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Induced Pluripotent Stem Cells Production market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Induced Pluripotent Stem Cells Production manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Axol Bioscience Ltd.
Evotec
Hitachi Ltd.
Merck KGaA
REPROCELL Inc.
Fate Therapeutics
Thermo Fisher Scientific, Inc.
StemCellFactory III
Applied StemCell Inc.
Segment by Type
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Others
Segment by Application
Academic Research
Drug Development
Toxicity Screening
Regenerative Medicine
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Induced Pluripotent Stem Cells Production manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Induced Pluripotent Stem Cells Production in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Induced Pluripotent Stem Cells (iPSC) are generated from skin or blood cells that have been reprogrammed into an embryonic-like pluripotent state, allowing to produce an infinite source of any kind of human cell required for therapeutic reasons.
The global Induced Pluripotent Stem Cells Production market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Induced Pluripotent Stem Cells Production is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Induced Pluripotent Stem Cells Production is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Induced Pluripotent Stem Cells Production include Lonza, Axol Bioscience Ltd., Evotec, Hitachi Ltd., Merck KGaA, REPROCELL Inc., Fate Therapeutics, Thermo Fisher Scientific, Inc. and StemCellFactory III, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Induced Pluripotent Stem Cells Production, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Induced Pluripotent Stem Cells Production.
Report Scope
The Induced Pluripotent Stem Cells Production market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Induced Pluripotent Stem Cells Production market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Induced Pluripotent Stem Cells Production manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Axol Bioscience Ltd.
Evotec
Hitachi Ltd.
Merck KGaA
REPROCELL Inc.
Fate Therapeutics
Thermo Fisher Scientific, Inc.
StemCellFactory III
Applied StemCell Inc.
Segment by Type
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Others
Segment by Application
Academic Research
Drug Development
Toxicity Screening
Regenerative Medicine
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Induced Pluripotent Stem Cells Production manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Induced Pluripotent Stem Cells Production in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Induced Pluripotent Stem Cells Production Market Overview
1.1 Product Overview and Scope of Induced Pluripotent Stem Cells Production
1.2 Induced Pluripotent Stem Cells Production Segment by Type
1.2.1 Global Induced Pluripotent Stem Cells Production Market Value Comparison by Type (2024-2030)
1.2.2 Hepatocytes
1.2.3 Fibroblasts
1.2.4 Keratinocytes
1.2.5 Amniotic Cells
1.2.6 Others
1.3 Induced Pluripotent Stem Cells Production Segment by Application
1.3.1 Global Induced Pluripotent Stem Cells Production Market Value by Application: (2024-2030)
1.3.2 Academic Research
1.3.3 Drug Development
1.3.4 Toxicity Screening
1.3.5 Regenerative Medicine
1.4 Global Induced Pluripotent Stem Cells Production Market Size Estimates and Forecasts
1.4.1 Global Induced Pluripotent Stem Cells Production Revenue 2019-2030
1.4.2 Global Induced Pluripotent Stem Cells Production Sales 2019-2030
1.4.3 Global Induced Pluripotent Stem Cells Production Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Induced Pluripotent Stem Cells Production Market Competition by Manufacturers
2.1 Global Induced Pluripotent Stem Cells Production Sales Market Share by Manufacturers (2019-2024)
2.2 Global Induced Pluripotent Stem Cells Production Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Induced Pluripotent Stem Cells Production Average Price by Manufacturers (2019-2024)
2.4 Global Induced Pluripotent Stem Cells Production Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Induced Pluripotent Stem Cells Production, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Induced Pluripotent Stem Cells Production, Product Type & Application
2.7 Induced Pluripotent Stem Cells Production Market Competitive Situation and Trends
2.7.1 Induced Pluripotent Stem Cells Production Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Induced Pluripotent Stem Cells Production Players Market Share by Revenue
2.7.3 Global Induced Pluripotent Stem Cells Production Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Induced Pluripotent Stem Cells Production Retrospective Market Scenario by Region
3.1 Global Induced Pluripotent Stem Cells Production Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Induced Pluripotent Stem Cells Production Global Induced Pluripotent Stem Cells Production Sales by Region: 2019-2030
3.2.1 Global Induced Pluripotent Stem Cells Production Sales by Region: 2019-2024
3.2.2 Global Induced Pluripotent Stem Cells Production Sales by Region: 2025-2030
3.3 Global Induced Pluripotent Stem Cells Production Global Induced Pluripotent Stem Cells Production Revenue by Region: 2019-2030
3.3.1 Global Induced Pluripotent Stem Cells Production Revenue by Region: 2019-2024
3.3.2 Global Induced Pluripotent Stem Cells Production Revenue by Region: 2025-2030
3.4 North America Induced Pluripotent Stem Cells Production Market Facts & Figures by Country
3.4.1 North America Induced Pluripotent Stem Cells Production Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Induced Pluripotent Stem Cells Production Sales by Country (2019-2030)
3.4.3 North America Induced Pluripotent Stem Cells Production Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Induced Pluripotent Stem Cells Production Market Facts & Figures by Country
3.5.1 Europe Induced Pluripotent Stem Cells Production Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Induced Pluripotent Stem Cells Production Sales by Country (2019-2030)
3.5.3 Europe Induced Pluripotent Stem Cells Production Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Induced Pluripotent Stem Cells Production Market Facts & Figures by Country
3.6.1 Asia Pacific Induced Pluripotent Stem Cells Production Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Induced Pluripotent Stem Cells Production Sales by Country (2019-2030)
3.6.3 Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Induced Pluripotent Stem Cells Production Market Facts & Figures by Country
3.7.1 Latin America Induced Pluripotent Stem Cells Production Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Induced Pluripotent Stem Cells Production Sales by Country (2019-2030)
3.7.3 Latin America Induced Pluripotent Stem Cells Production Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Induced Pluripotent Stem Cells Production Market Facts & Figures by Country
3.8.1 Middle East and Africa Induced Pluripotent Stem Cells Production Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Induced Pluripotent Stem Cells Production Sales by Country (2019-2030)
3.8.3 Middle East and Africa Induced Pluripotent Stem Cells Production Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Induced Pluripotent Stem Cells Production Sales by Type (2019-2030)
4.1.1 Global Induced Pluripotent Stem Cells Production Sales by Type (2019-2024)
4.1.2 Global Induced Pluripotent Stem Cells Production Sales by Type (2025-2030)
4.1.3 Global Induced Pluripotent Stem Cells Production Sales Market Share by Type (2019-2030)
4.2 Global Induced Pluripotent Stem Cells Production Revenue by Type (2019-2030)
4.2.1 Global Induced Pluripotent Stem Cells Production Revenue by Type (2019-2024)
4.2.2 Global Induced Pluripotent Stem Cells Production Revenue by Type (2025-2030)
4.2.3 Global Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2019-2030)
4.3 Global Induced Pluripotent Stem Cells Production Price by Type (2019-2030)
5 Segment by Application
5.1 Global Induced Pluripotent Stem Cells Production Sales by Application (2019-2030)
5.1.1 Global Induced Pluripotent Stem Cells Production Sales by Application (2019-2024)
5.1.2 Global Induced Pluripotent Stem Cells Production Sales by Application (2025-2030)
5.1.3 Global Induced Pluripotent Stem Cells Production Sales Market Share by Application (2019-2030)
5.2 Global Induced Pluripotent Stem Cells Production Revenue by Application (2019-2030)
5.2.1 Global Induced Pluripotent Stem Cells Production Revenue by Application (2019-2024)
5.2.2 Global Induced Pluripotent Stem Cells Production Revenue by Application (2025-2030)
5.2.3 Global Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2019-2030)
5.3 Global Induced Pluripotent Stem Cells Production Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Lonza
6.1.1 Lonza Corporation Information
6.1.2 Lonza Description and Business Overview
6.1.3 Lonza Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Lonza Induced Pluripotent Stem Cells Production Product Portfolio
6.1.5 Lonza Recent Developments/Updates
6.2 Axol Bioscience Ltd.
6.2.1 Axol Bioscience Ltd. Corporation Information
6.2.2 Axol Bioscience Ltd. Description and Business Overview
6.2.3 Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Product Portfolio
6.2.5 Axol Bioscience Ltd. Recent Developments/Updates
6.3 Evotec
6.3.1 Evotec Corporation Information
6.3.2 Evotec Description and Business Overview
6.3.3 Evotec Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Evotec Induced Pluripotent Stem Cells Production Product Portfolio
6.3.5 Evotec Recent Developments/Updates
6.4 Hitachi Ltd.
6.4.1 Hitachi Ltd. Corporation Information
6.4.2 Hitachi Ltd. Description and Business Overview
6.4.3 Hitachi Ltd. Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hitachi Ltd. Induced Pluripotent Stem Cells Production Product Portfolio
6.4.5 Hitachi Ltd. Recent Developments/Updates
6.5 Merck KGaA
6.5.1 Merck KGaA Corporation Information
6.5.2 Merck KGaA Description and Business Overview
6.5.3 Merck KGaA Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merck KGaA Induced Pluripotent Stem Cells Production Product Portfolio
6.5.5 Merck KGaA Recent Developments/Updates
6.6 REPROCELL Inc.
6.6.1 REPROCELL Inc. Corporation Information
6.6.2 REPROCELL Inc. Description and Business Overview
6.6.3 REPROCELL Inc. Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2019-2024)
6.6.4 REPROCELL Inc. Induced Pluripotent Stem Cells Production Product Portfolio
6.6.5 REPROCELL Inc. Recent Developments/Updates
6.7 Fate Therapeutics
6.6.1 Fate Therapeutics Corporation Information
6.6.2 Fate Therapeutics Description and Business Overview
6.6.3 Fate Therapeutics Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fate Therapeutics Induced Pluripotent Stem Cells Production Product Portfolio
6.7.5 Fate Therapeutics Recent Developments/Updates
6.8 Thermo Fisher Scientific, Inc.
6.8.1 Thermo Fisher Scientific, Inc. Corporation Information
6.8.2 Thermo Fisher Scientific, Inc. Description and Business Overview
6.8.3 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Product Portfolio
6.8.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates
6.9 StemCellFactory III
6.9.1 StemCellFactory III Corporation Information
6.9.2 StemCellFactory III Description and Business Overview
6.9.3 StemCellFactory III Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2019-2024)
6.9.4 StemCellFactory III Induced Pluripotent Stem Cells Production Product Portfolio
6.9.5 StemCellFactory III Recent Developments/Updates
6.10 Applied StemCell Inc.
6.10.1 Applied StemCell Inc. Corporation Information
6.10.2 Applied StemCell Inc. Description and Business Overview
6.10.3 Applied StemCell Inc. Induced Pluripotent Stem Cells Production Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Applied StemCell Inc. Induced Pluripotent Stem Cells Production Product Portfolio
6.10.5 Applied StemCell Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Induced Pluripotent Stem Cells Production Industry Chain Analysis
7.2 Induced Pluripotent Stem Cells Production Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Induced Pluripotent Stem Cells Production Production Mode & Process
7.4 Induced Pluripotent Stem Cells Production Sales and Marketing
7.4.1 Induced Pluripotent Stem Cells Production Sales Channels
7.4.2 Induced Pluripotent Stem Cells Production Distributors
7.5 Induced Pluripotent Stem Cells Production Customers
8 Induced Pluripotent Stem Cells Production Market Dynamics
8.1 Induced Pluripotent Stem Cells Production Industry Trends
8.2 Induced Pluripotent Stem Cells Production Market Drivers
8.3 Induced Pluripotent Stem Cells Production Market Challenges
8.4 Induced Pluripotent Stem Cells Production Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Induced Pluripotent Stem Cells Production Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Induced Pluripotent Stem Cells Production Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Induced Pluripotent Stem Cells Production Market Competitive Situation by Manufacturers in 2023
Table 4. Global Induced Pluripotent Stem Cells Production Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Induced Pluripotent Stem Cells Production Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Induced Pluripotent Stem Cells Production Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Induced Pluripotent Stem Cells Production Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Induced Pluripotent Stem Cells Production Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Induced Pluripotent Stem Cells Production, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Induced Pluripotent Stem Cells Production, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Induced Pluripotent Stem Cells Production, Product Type & Application
Table 12. Global Key Manufacturers of Induced Pluripotent Stem Cells Production, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Induced Pluripotent Stem Cells Production by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Induced Pluripotent Stem Cells Production as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Induced Pluripotent Stem Cells Production Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Induced Pluripotent Stem Cells Production Sales by Region (2019-2024) & (K Units)
Table 18. Global Induced Pluripotent Stem Cells Production Sales Market Share by Region (2019-2024)
Table 19. Global Induced Pluripotent Stem Cells Production Sales by Region (2025-2030) & (K Units)
Table 20. Global Induced Pluripotent Stem Cells Production Sales Market Share by Region (2025-2030)
Table 21. Global Induced Pluripotent Stem Cells Production Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Region (2019-2024)
Table 23. Global Induced Pluripotent Stem Cells Production Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Region (2025-2030)
Table 25. North America Induced Pluripotent Stem Cells Production Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Induced Pluripotent Stem Cells Production Sales by Country (2019-2024) & (K Units)
Table 27. North America Induced Pluripotent Stem Cells Production Sales by Country (2025-2030) & (K Units)
Table 28. North America Induced Pluripotent Stem Cells Production Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Induced Pluripotent Stem Cells Production Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Induced Pluripotent Stem Cells Production Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Induced Pluripotent Stem Cells Production Sales by Country (2019-2024) & (K Units)
Table 32. Europe Induced Pluripotent Stem Cells Production Sales by Country (2025-2030) & (K Units)
Table 33. Europe Induced Pluripotent Stem Cells Production Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Induced Pluripotent Stem Cells Production Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Induced Pluripotent Stem Cells Production Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Induced Pluripotent Stem Cells Production Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Induced Pluripotent Stem Cells Production Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Induced Pluripotent Stem Cells Production Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Induced Pluripotent Stem Cells Production Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Induced Pluripotent Stem Cells Production Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Induced Pluripotent Stem Cells Production Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Induced Pluripotent Stem Cells Production Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Induced Pluripotent Stem Cells Production Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Induced Pluripotent Stem Cells Production Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Induced Pluripotent Stem Cells Production Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Induced Pluripotent Stem Cells Production Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Induced Pluripotent Stem Cells Production Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Induced Pluripotent Stem Cells Production Sales (K Units) by Type (2019-2024)
Table 51. Global Induced Pluripotent Stem Cells Production Sales (K Units) by Type (2025-2030)
Table 52. Global Induced Pluripotent Stem Cells Production Sales Market Share by Type (2019-2024)
Table 53. Global Induced Pluripotent Stem Cells Production Sales Market Share by Type (2025-2030)
Table 54. Global Induced Pluripotent Stem Cells Production Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Induced Pluripotent Stem Cells Production Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2019-2024)
Table 57. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Type (2025-2030)
Table 58. Global Induced Pluripotent Stem Cells Production Price (USD/Unit) by Type (2019-2024)
Table 59. Global Induced Pluripotent Stem Cells Production Price (USD/Unit) by Type (2025-2030)
Table 60. Global Induced Pluripotent Stem Cells Production Sales (K Units) by Application (2019-2024)
Table 61. Global Induced Pluripotent Stem Cells Production Sales (K Units) by Application (2025-2030)
Table 62. Global Induced Pluripotent Stem Cells Production Sales Market Share by Application (2019-2024)
Table 63. Global Induced Pluripotent Stem Cells Production Sales Market Share by Application (2025-2030)
Table 64. Global Induced Pluripotent Stem Cells Production Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Induced Pluripotent Stem Cells Production Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2019-2024)
Table 67. Global Induced Pluripotent Stem Cells Production Revenue Market Share by Application (2025-2030)
Table 68. Global Induced Pluripotent Stem Cells Production Price (USD/Unit) by Application (2019-2024)
Table 69. Global Induced Pluripotent Stem Cells Production Price (USD/Unit) by Application (2025-2030)
Table 70. Lonza Corporation Information
Table 71. Lonza Description and Business Overview
Table 72. Lonza Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Lonza Induced Pluripotent Stem Cells Production Product
Table 74. Lonza Recent Developments/Updates
Table 75. Axol Bioscience Ltd. Corporation Information
Table 76. Axol Bioscience Ltd. Description and Business Overview
Table 77. Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Axol Bioscience Ltd. Induced Pluripotent Stem Cells Production Product
Table 79. Axol Bioscience Ltd. Recent Developments/Updates
Table 80. Evotec Corporation Information
Table 81. Evotec Description and Business Overview
Table 82. Evotec Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Evotec Induced Pluripotent Stem Cells Production Product
Table 84. Evotec Recent Developments/Updates
Table 85. Hitachi Ltd. Corporation Information
Table 86. Hitachi Ltd. Description and Business Overview
Table 87. Hitachi Ltd. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Hitachi Ltd. Induced Pluripotent Stem Cells Production Product
Table 89. Hitachi Ltd. Recent Developments/Updates
Table 90. Merck KGaA Corporation Information
Table 91. Merck KGaA Description and Business Overview
Table 92. Merck KGaA Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Merck KGaA Induced Pluripotent Stem Cells Production Product
Table 94. Merck KGaA Recent Developments/Updates
Table 95. REPROCELL Inc. Corporation Information
Table 96. REPROCELL Inc. Description and Business Overview
Table 97. REPROCELL Inc. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. REPROCELL Inc. Induced Pluripotent Stem Cells Production Product
Table 99. REPROCELL Inc. Recent Developments/Updates
Table 100. Fate Therapeutics Corporation Information
Table 101. Fate Therapeutics Description and Business Overview
Table 102. Fate Therapeutics Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Fate Therapeutics Induced Pluripotent Stem Cells Production Product
Table 104. Fate Therapeutics Recent Developments/Updates
Table 105. Thermo Fisher Scientific, Inc. Corporation Information
Table 106. Thermo Fisher Scientific, Inc. Description and Business Overview
Table 107. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells Production Product
Table 109. Thermo Fisher Scientific, Inc. Recent Developments/Updates
Table 110. StemCellFactory III Corporation Information
Table 111. StemCellFactory III Description and Business Overview
Table 112. StemCellFactory III Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. StemCellFactory III Induced Pluripotent Stem Cells Production Product
Table 114. StemCellFactory III Recent Developments/Updates
Table 115. Applied StemCell Inc. Corporation Information
Table 116. Applied StemCell Inc. Description and Business Overview
Table 117. Applied StemCell Inc. Induced Pluripotent Stem Cells Production Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Applied StemCell Inc. Induced Pluripotent Stem Cells Production Product
Table 119. Applied StemCell Inc. Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Induced Pluripotent Stem Cells Production Distributors List
Table 123. Induced Pluripotent Stem Cells Production Customers List
Table 124. Induced Pluripotent Stem Cells Production Market Trends
Table 125. Induced Pluripotent Stem Cells Production Market Drivers
Table 126. Induced Pluripotent Stem Cells Production Market Challenges
Table 127. Induced Pluripotent Stem Cells Production Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Induced Pluripotent Stem Cells Production
Figure 2. Global Induced Pluripotent Stem Cells Production Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Induced Pluripotent Stem Cells Production Market Share by Type in 2023 & 2030
Figure 4. Hepatocytes Product Picture
Figure 5. Fibroblasts Product Picture
Figure 6. Keratinocytes Product Picture
Figure 7. Amniotic Cells Product Picture
Figure 8. Others Product Picture
Figure 9. Global Induced Pluripotent Stem Cells Production Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Induced Pluripotent Stem Cells Production Market Share by Application in 2023 & 2030
Figure 11. Academic Research
Figure 12. Drug Development
Figure 13. Toxicity Screening
Figure 14. Regenerative Medicine
Figure 15. Global Induced Pluripotent Stem Cells Production Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Induced Pluripotent Stem Cells Production Market Size (2019-2030) & (US$ Million)
Figure 17. Global Induced Pluripotent Stem Cells Production Sales (2019-2030) & (K Units)
Figure 18. Global Induced Pluripotent Stem Cells Production Average Price (USD/Unit) & (2019-2030)
Figure 19. Induced Pluripotent Stem Cells Production Report Years Considered
Figure 20. Induced Pluripotent Stem Cells Production Sales Share by Manufacturers in 2023
Figure 21. Global Induced Pluripotent Stem Cells Production Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Induced Pluripotent Stem Cells Production Players: Market Share by Revenue in 2023
Figure 23. Induced Pluripotent Stem Cells Production Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Induced Pluripotent Stem Cells Production Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Induced Pluripotent Stem Cells Production Sales Market Share by Country (2019-2030)
Figure 26. North America Induced Pluripotent Stem Cells Production Revenue Market Share by Country (2019-2030)
Figure 27. United States Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Induced Pluripotent Stem Cells Production Sales Market Share by Country (2019-2030)
Figure 30. Europe Induced Pluripotent Stem Cells Production Revenue Market Share by Country (2019-2030)
Figure 31. Germany Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Induced Pluripotent Stem Cells Production Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Induced Pluripotent Stem Cells Production Revenue Market Share by Region (2019-2030)
Figure 38. China Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Induced Pluripotent Stem Cells Production Sales Market Share by Country (2019-2030)
Figure 48. Latin America Induced Pluripotent Stem Cells Production Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Induced Pluripotent Stem Cells Production Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Induced Pluripotent Stem Cells Production Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. UAE Induced Pluripotent Stem Cells Production Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Induced Pluripotent Stem Cells Production by Type (2019-2030)
Figure 58. Global Revenue Market Share of Induced Pluripotent Stem Cells Production by Type (2019-2030)
Figure 59. Global Induced Pluripotent Stem Cells Production Price (USD/Unit) by Type (2019-2030)
Figure 60. Global Sales Market Share of Induced Pluripotent Stem Cells Production by Application (2019-2030)
Figure 61. Global Revenue Market Share of Induced Pluripotent Stem Cells Production by Application (2019-2030)
Figure 62. Global Induced Pluripotent Stem Cells Production Price (USD/Unit) by Application (2019-2030)
Figure 63. Induced Pluripotent Stem Cells Production Value Chain
Figure 64. Induced Pluripotent Stem Cells Production Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
